Price: $6.67
(as of Aug 20, 2025 05:31:02 UTC – Details)
Introduction to Nauzene
Nauzene is a doctor-recommended, specially buffered formula designed to quickly relieve stomach discomfort from overindulging in food and drink. It also helps to calm and control upset stomach discomfort, including nausea and upset stomach experienced while taking GLP-1 drugs.
Features
- Quick Relief: Nauzene’s four-minute formula provides fast relief from stomach discomfort.
- Buffered Formula: Specially designed to calm and control upset stomach discomfort.
- Relief from Nausea: Helps to relieve nausea, especially when taking GLP-1 drugs.
- Convenient: Available in quick-dissolving, wild cherry flavored chewable tablets.
- No Salicylates, Caffeine, or Antihistamines: Makes it a safer option for those sensitive to these ingredients.
- Delicious Flavor: Wild Cherry flavor without a chalky medicinal taste or bitter aftertaste.
Pros
- Fast Acting: Reaches 99% of its acid neutralizing ability within 4 minutes.
- Safe Ingredients: Does not contain aspirin, other salicylates, caffeine, or antihistamines.
- Convenient and Tasty: Quick-dissolving tablets with a pleasant wild cherry flavor.
- Doctor-Recommended: Backed by medical professionals for its effectiveness.
- Highly Rated: With a 4.6 out of 5 stars rating from over 3,033 customer reviews.
Cons
- Limited Information on Long-Term Use: There might be limited data available on the effects of long-term use.
- May Not Be Suitable for Everyone: As with any medication, it may have interactions with other drugs or not be suitable for certain health conditions.
- Dependence on Customer Reviews: The perception of its effectiveness might heavily rely on customer reviews and personal experiences.
Product Details
- Product Dimensions: 1.5 x 2.75 x 4.88 inches; 3.33 ounces
- Item Model Number: A42056
- Date First Available: October 14, 2019
- Manufacturer: AmazonUs/ALVE7
- ASIN: B07Y9361N3
- Best Sellers Rank: #5,592 in Health & Household, #27 in Antinausea Treatments
Reviews
There are no reviews yet.